Athena Tech Information

Athena Tech turns unstructured oncology clinical data into structured real-world evidence, in days instead of months. Our platform, OncoCraft, activates oncological data to pharma teams, CROs, and hospitals across 50+ cancer types. Built by the same team behind Athena Xarxa Melanoma, the clinical registry managing 24,000+ patients across 35+ institutions in Catalonia over 20 years of longitudinal data. Spin-off from Hospital Clínic de Barcelona's Melanoma Unit, one of the world's largest melanoma research groups. Backed by the European Union's Horizon Europe programme through the MELCAYA consortium — Grant No. 101096667, €8M. How the platform works: ▸ Extracts structured data from PDFs, pathology reports, clinical notes, and voice memos using AI. ▸ Multi-tenant environments with role-based access. Each institution gets an isolated workspace. ▸ Natural-language analytics over patient cohorts, clinical trial matching, cohort-level dashboards. ▸ Domain-specific data models for each cancer type, not generic forms. Products: ▸ OncoCraft (beta, April 2026) Pan-cancer platform supporting 50+ cancer types. ▸ Athena Xarxa Melanoma (XXMM) Clinical melanoma registry in production at 35+ institutions across Catalonia. 24,000+ patients, 20 years of longitudinal data. ▸ Manuscript under review: "Episode-Based Melanoma Risk Stratification Using Artificial Intelligence" (6,327 patients, 12 institutions, time-updated survival models with SHAP interpretability, TRIPOD+AI compliant). ▸ Infrastructure: GDPR-compliant, HIPAA-equivalent, deployed in European Azure regions under a Business Associate Agreement with Microsoft. Multi-tenant, encrypted, full audit trails, role-based access control.